As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when prices are capped and whether short-term savings for consumers come at the expense of future medical breakthroughs.On Friday, Trump announced deals with nine pharmaceutical companies to lower prices on certain medications for Americans, along with $150 billion in promised new investments in domestic manufacturing and pharmaceutical research.The announcement builds on the administration’s Trump Rx initiative, a government-run portal designed to steer...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free
